Recorded: 30 May 2003
It was the competition for the overall project. It wasn’t for small parts of it, or competing for the same drug or something like that. I mean the small scale biological research is extremely competitive between different laboratories working on what the next protein in a cascade is. So that competition is common. And that’s between public and private, and private and private and public and public. But this is competition that is really at a much bigger level. This was competition for the whole project. If Celera had done it by themselves, then the information that was available to people like us would be completely different.
Peter Little is a bioinformatics researcher, professor of medical biochemistry and the head of the School of Biotechnology and Biomolecular Sciences at the University of New South Wales in Sydney, Australia. He received his Ph.D. working with recombinant DNA under Ed Southern and Peter Walker at Edinburgh University. In 1976, Little cloned a human gene – the second time this was ever accomplished.
Little’s laboratory studies the genetic basis of gene expression, and genetic variation as it pertains to the regulatory regions of the genes. He has hypothesized that there are two types of genetic variation that alter gene expression. His lab has also created advanced techniques for testing genetically influenced transcript variations.
He comes to Cold Spring Harbor Laboratory regularly for genome meetings and symposia.